Testing of people infected by SARS-CoV-2 and tracking of contacts allows more appropriate public health precautions to be put in place, but is usually insufficient to inhibit the virus’ spreading. Amongst existing diagnostic methods, PCR testing is the benchmark, but is limited by the capacities of laboratories, the cost of the test, and the waiting time for results, usually more than 24 hours. On the other hand, antigen tests are more adapted to mass testing since they can be manufactured in huge quantities, are inexpensive and give a result in less than 30 minutes. However, they are much less sensitive and only allow around 70% of infections to be detected. Slovakian researchers and scientists at the London School of Hygiene and Tropical Medicine have evaluated the impact of mass rapid-testing, carried out in Slovakia, on the transmission of the virus across the country.
Slovakia carried out several mass antigen test operations in October and November 2020: a pilot study over 4 regions, then a national campaign, and then a second campaign 7 days later in the most affected regions. In total, more than 5 million rapid antigen tests were performed.